Terri Rosel, NP
Nurse Practitioner · Caledonia, MINPI 1326270760
Payments from drug & device makers
Across 51 payments — averaging $57.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- Supernus Pharmaceuticals, Inc.$824
- Otsuka America Pharmaceutical, Inc.$125
- E.r. Squibb & Sons, L.L.C.$85
- Lundbeck LLC$15
- Kowa Pharmaceuticals America, Inc.$14
What the payments were for
- Speaking & faculty fees$1,80061%
- Travel & lodging$722%
- Food & beverage$1,07236%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 4 | $1,889 |
| Supernus Pharmaceuticals, Inc. | 43 | $824 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $85 |
| Lundbeck LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NGENLA$1,800
- ABILIFY MAINTENA$125
How this compares
$2,951 in reported general payments places this provider in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 17 | $12,754 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 37 | $2,401 |
| Vilazodone Hcl | 16 | $2,140 |
| Aripiprazole | 100 | $2,058 |
| Bupropion XlBupropion Hcl | 110 | $1,898 |
| Mirtazapine | 84 | $1,770 |
| Olanzapine | 74 | $1,458 |
| Lurasidone Hcl | 61 | $1,414 |
| Atomoxetine Hcl | 23 | $1,407 |
| Quetiapine Fumarate | 118 | $1,213 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 70 | $1,208 |
| Buspirone Hcl | 76 | $980 |
| Duloxetine Hcl | 50 | $890 |
| Trazodone Hcl | 85 | $850 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $674 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Caledonia
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Elizabeth KirshnerAnn Arbor$119K
- Lisa Astalos ChismWoodhaven$103K
- Martha GoetzPetoskey$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.